Evidence map›Paper›PMID 40348839›Full record

ArticleCommunications medicine2025

The non-cytotoxic small molecule NPB does not inhibit BAD phosphorylation and forms colloidal aggregates.

John Maringa Githaka, Tomás Gutiérrez, Zhuang Zhuang Han, Joseph O Primeau, Heather Muranyi, Howard S Young, Brian D Sykes, Olivier Julien, Ing Swie Goping

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

John Maringa Githaka *Departments of Biochemistry, University of Alberta, Edmonton, AB, Canada.ORCID http://orcid.org/0000-0003-1974-0415
Tomás Gutiérrez *Departments of Biochemistry, University of Alberta, Edmonton, AB, Canada.ORCID http://orcid.org/0000-0002-5218-2286
Zhuang Zhuang HanDepartments of Biochemistry, University of Alberta, Edmonton, AB, Canada.
Joseph O PrimeauDepartments of Biochemistry, University of Alberta, Edmonton, AB, Canada.ORCID http://orcid.org/0000-0001-9734-3736
Heather MuranyiDepartments of Biochemistry, University of Alberta, Edmonton, AB, Canada.
Howard S YoungDepartments of Biochemistry, University of Alberta, Edmonton, AB, Canada.
Brian D SykesDepartments of Biochemistry, University of Alberta, Edmonton, AB, Canada.
Olivier JulienDepartments of Biochemistry, University of Alberta, Edmonton, AB, Canada. ojulien@ualberta.ca.ORCID http://orcid.org/0000-0001-7068-7299
Ing Swie GopingDepartments of Biochemistry, University of Alberta, Edmonton, AB, Canada. igoping@ualberta.ca.ORCID http://orcid.org/0000-0001-6355-827X

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 419793
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40348839
PMCPMC12065803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.